Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers

Abstract The activating TERT promoter mutations and BRAF V600E mutation are well-established oncogenic alterations in human cancers. Coexistence of BRAF V600E and TERT promoter mutations is frequently found in multiple cancer types, and is strongly associated with poor patient prognosis. Although th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yongxing Wu, Liang Shi, Yuelei Zhao, Pu Chen, Rongrong Cui, Meiju Ji, Nongyue He, Maode Wang, Gang Li, Peng Hou
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/8960613512794ea8858c81b1f6b48e74
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8960613512794ea8858c81b1f6b48e74
record_format dspace
spelling oai:doaj.org-article:8960613512794ea8858c81b1f6b48e742021-12-02T13:43:59ZSynergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers10.1038/s41698-020-00140-52397-768Xhttps://doaj.org/article/8960613512794ea8858c81b1f6b48e742021-01-01T00:00:00Zhttps://doi.org/10.1038/s41698-020-00140-5https://doaj.org/toc/2397-768XAbstract The activating TERT promoter mutations and BRAF V600E mutation are well-established oncogenic alterations in human cancers. Coexistence of BRAF V600E and TERT promoter mutations is frequently found in multiple cancer types, and is strongly associated with poor patient prognosis. Although the BRAFV600E-elicited activation of ERK has been demonstrated to contribute to TERT reactivation by maintaining an active chromatin state, it still remains to be addressed how activated ERK is selectively recruited to mutant TERT promoter. Here, we report that transcription factor GABPA mediates the regulation of BRAFV600E/MAPK signaling on TERT reactivation by selectively recruiting activated ERK to mutant TERT promoter, where activated ERK can phosphorylate Sp1, thereby resulting in HDAC1 dissociation and an active chromatin state. Meanwhile, phosphorylated Sp1 further enhances the binding of GABPA to mutant TERT promoter. Taken together, our data indicate that GABPA and Sp1 synergistically activate mutant TERT promoter, contributing to tumorigenesis and cancer progression, particularly in the BRAFV600E-driven human cancers. Thus, our findings identify a direct mechanism that bridges two frequent oncogenic alterations together in TERT reactivation.Yongxing WuLiang ShiYuelei ZhaoPu ChenRongrong CuiMeiju JiNongyue HeMaode WangGang LiPeng HouNature PortfolioarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Precision Oncology, Vol 5, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Yongxing Wu
Liang Shi
Yuelei Zhao
Pu Chen
Rongrong Cui
Meiju Ji
Nongyue He
Maode Wang
Gang Li
Peng Hou
Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers
description Abstract The activating TERT promoter mutations and BRAF V600E mutation are well-established oncogenic alterations in human cancers. Coexistence of BRAF V600E and TERT promoter mutations is frequently found in multiple cancer types, and is strongly associated with poor patient prognosis. Although the BRAFV600E-elicited activation of ERK has been demonstrated to contribute to TERT reactivation by maintaining an active chromatin state, it still remains to be addressed how activated ERK is selectively recruited to mutant TERT promoter. Here, we report that transcription factor GABPA mediates the regulation of BRAFV600E/MAPK signaling on TERT reactivation by selectively recruiting activated ERK to mutant TERT promoter, where activated ERK can phosphorylate Sp1, thereby resulting in HDAC1 dissociation and an active chromatin state. Meanwhile, phosphorylated Sp1 further enhances the binding of GABPA to mutant TERT promoter. Taken together, our data indicate that GABPA and Sp1 synergistically activate mutant TERT promoter, contributing to tumorigenesis and cancer progression, particularly in the BRAFV600E-driven human cancers. Thus, our findings identify a direct mechanism that bridges two frequent oncogenic alterations together in TERT reactivation.
format article
author Yongxing Wu
Liang Shi
Yuelei Zhao
Pu Chen
Rongrong Cui
Meiju Ji
Nongyue He
Maode Wang
Gang Li
Peng Hou
author_facet Yongxing Wu
Liang Shi
Yuelei Zhao
Pu Chen
Rongrong Cui
Meiju Ji
Nongyue He
Maode Wang
Gang Li
Peng Hou
author_sort Yongxing Wu
title Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers
title_short Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers
title_full Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers
title_fullStr Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers
title_full_unstemmed Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers
title_sort synergistic activation of mutant tert promoter by sp1 and gabpa in brafv600e-driven human cancers
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/8960613512794ea8858c81b1f6b48e74
work_keys_str_mv AT yongxingwu synergisticactivationofmutanttertpromoterbysp1andgabpainbrafv600edrivenhumancancers
AT liangshi synergisticactivationofmutanttertpromoterbysp1andgabpainbrafv600edrivenhumancancers
AT yueleizhao synergisticactivationofmutanttertpromoterbysp1andgabpainbrafv600edrivenhumancancers
AT puchen synergisticactivationofmutanttertpromoterbysp1andgabpainbrafv600edrivenhumancancers
AT rongrongcui synergisticactivationofmutanttertpromoterbysp1andgabpainbrafv600edrivenhumancancers
AT meijuji synergisticactivationofmutanttertpromoterbysp1andgabpainbrafv600edrivenhumancancers
AT nongyuehe synergisticactivationofmutanttertpromoterbysp1andgabpainbrafv600edrivenhumancancers
AT maodewang synergisticactivationofmutanttertpromoterbysp1andgabpainbrafv600edrivenhumancancers
AT gangli synergisticactivationofmutanttertpromoterbysp1andgabpainbrafv600edrivenhumancancers
AT penghou synergisticactivationofmutanttertpromoterbysp1andgabpainbrafv600edrivenhumancancers
_version_ 1718392507295858688